Post-tuberculosis lung disease (PTLD)
What is post-tuberculosis lung disease?
Post-tuberculosis lung disease, also known as post-TB lung sequelae or post-TB lung impairment, refers to the long-term complications that can arise in the lungs following the successful treatment of pulmonary tuberculosis (TB).
Despite effective treatment and cure of TB, some individuals may experience residual lung damage and functional impairment. This condition can have a considerable effect on the quality of life and respiratory function of those affected.
WHAT ARE THE SIGNS?
Signs and symptoms of post-tuberculosis lung disease can vary depending on the severity of lung damage. Common manifestations may include:
- Chronic cough
- Shortness of breath, especially during exertion
- Persistent chest pain
- Fatigue
- Recurrent respiratory infections
- Haemoptysis (coughing up blood)
- Wheezing or noisy breathing
HOW IS POST-TUBERCULOSIS LUNG DISEASE DIAGNOSED?
Diagnosis of post-tuberculosis lung disease typically involves a combination of clinical evaluation, medical history assessment, and diagnostic tests. Key steps in the diagnostic process may include:
- Medical history: The physician will inquire about the patient's history of tuberculosis infection, including details of past treatment and any lingering respiratory symptoms.
- Physical examination: A thorough examination of the chest may reveal signs such as diminished breath sounds, crackles, or wheezing.
- Imaging studies: Chest X-rays or computed tomography (CT) scans can help identify characteristic abnormalities such as fibrotic changes, cavities, bronchiectasis, or pleural thickening, which are indicative of post-tuberculosis lung disease.
- Pulmonary function tests (PFTs): These tests assess lung function parameters such as lung capacity, airflow, and gas exchange, providing valuable information about the extent of respiratory impairment.
- Sputum culture: In some cases, sputum samples may be collected to rule out active TB infection or identify secondary respiratory pathogens.
HOW DO YOU TREAT POST-TUBERCULOSIS LUNG DISEASE?
Management of post-tuberculosis lung disease aims to alleviate symptoms, prevent disease progression, and improve overall respiratory function. Treatment strategies may include:
- Bronchodilators: These are recommended to help relax the airway muscles, improve airflow, and relieve symptoms of bronchospasm and wheezing.
- Inhaled corticosteroids: In individuals with persistent inflammation and airway hyperresponsiveness, inhaled corticosteroids may be prescribed to reduce airway inflammation and control symptoms.
- Oxygen therapy: Supplemental oxygen may be recommended for individuals with significant hypoxemia or respiratory failure to maintain adequate oxygenation and improve exercise tolerance.
- Pulmonary rehabilitation: A structured program involving exercise training, education, and psychosocial support can enhance functional capacity, alleviate dyspnoea, and improve quality of life.
- Management of complications: Treatment of complications such as respiratory infections, pulmonary hypertension, or respiratory failure may require a multidisciplinary approach involving specialists in pulmonology, infectious diseases, and critical care medicine.
- Lifestyle Modifications: Smoking cessation, avoidance of environmental pollutants, and vaccination against respiratory infections are essential components of long-term management to minimise exacerbations and preserve lung function.